Wellbutrin XL 300 mg (Bupropion Hydrochloride TABLET (EXTENDED-RELEASE)) 300 MG

Wellbutrin XL 300 mg is an extended-release tablet containing bupropion hydrochloride. It is commonly used to manage depression and aid in smoking cessation. This medication is designed for oral administration and is manufactured by Bausch Health, Canada Inc.

Strength

300 MG

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Wellbutrin XL 300 mg is primarily used for the management of major depressive disorder. It is also prescribed to help individuals quit smoking. The extended-release formulation ensures a steady release of the active ingredient, bupropion hydrochloride, throughout the day. People often ask, 'What is Wellbutrin XL used for?' and the answer includes its role in treating depression and supporting smoking cessation.

Side Effects

Common effects of Wellbutrin XL 300 mg may include dry mouth, insomnia, and headaches. Some users report increased energy levels and improved mood. As with any medication, individual experiences can vary, and it's important to monitor for any unusual symptoms.

Precautions & Warnings

Wellbutrin XL 300 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication should not be crushed or chewed, as it is designed for extended-release. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Wellbutrin XL 300 mg may interact with certain medications, including those that affect the central nervous system. Alcohol should be avoided while taking this medication, as it can increase the risk of side effects. It is also important to inform your healthcare provider about all other medications you are taking to avoid potential interactions.

Frequently Asked Questions

Wellbutrin XL 300 mg is used to manage major depressive disorder and aid in smoking cessation.

Wellbutrin XL 300 mg should be taken orally, whole, with water, and not crushed or chewed.

Common side effects may include dry mouth, insomnia, and headaches.

It is generally advised to avoid alcohol while taking Wellbutrin XL 300 mg to reduce the risk of side effects.

Wellbutrin XL 300 mg is manufactured by Bausch Health, Canada Inc.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.